Close Menu

NEW YORK – Prenatal and cancer molecular diagnostics company BillionToOne has come up with an unconventional way that could dramatically increase the number of available coronavirus diagnostic tests: a quantitative Sanger sequencing assay that harnesses the large existing base of capillary electrophoresis instruments in clinical laboratories.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.  

Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.